APO Research

APO RESEARCH · REPORT

Immune System Supplements

Selected research

Market Outlook & Growth Opportunities

Global Immune System Supplements Market Outlook and Growth Opportunities 2026

Market perspective

The global Immune System Supplements market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Immune System Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Immune System Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Immune System Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Immune System Supplements market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Immune System Supplements market include USANA Health Sciences, Swisse, Suntory, PERFECT, INFINITUS, Herbalife Nutrition, GNC, Glanbia and China New Era Group, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Immune System Supplements market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Immune System Supplements and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Immune System Supplements revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Immune System Supplements market.

Immune System Supplements Segment by Company

USANA Health Sciences

Swisse

Suntory

PERFECT

INFINITUS

Herbalife Nutrition

GNC

Glanbia

China New Era Group

By-health

Blackmores

Bayer AG

Amway

Immune System Supplements Segment by Type

Liquid

Soft Gels/Pills

Powder

Immune System Supplements Segment by Application

Online Sales

Offline Sales

Immune System Supplements Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Immune System Supplements status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Immune System Supplements key companies, revenue, market share, and recent developments.

3. To split the Immune System Supplements breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Immune System Supplements market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Immune System Supplements significant trends, drivers, influence factors in global and regions.

6. To analyze Immune System Supplements competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immune System Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immune System Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immune System Supplements.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Immune System Supplements industry.

Chapter 3: Detailed analysis of Immune System Supplements company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Immune System Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Immune System Supplements in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Immune System Supplements Industry Trends Table 2. Immune System Supplements Industry Drivers Table 3. Immune System Supplements Industry Opportunities and Challenges Table 4. Immune System Supplements Industry Restraints Table 5. Global Immune System Supplements Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Immune System Supplements Revenue Share by Company (2021-2026) Table 7. Global Immune System Supplements Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Immune System Supplements Key Company Manufacturing Base & Headquarters Table 9. Global Immune System Supplements Company, Product Type & Application Table 10. Global Immune System Supplements Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Immune System Supplements by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Liquid Table 15. Significant Companies of Soft Gels/Pills Table 16. Significant Companies of Powder Table 17. Global Immune System Supplements Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Immune System Supplements Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Immune System Supplements Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Immune System Supplements Sales Value Share by Type (2021-2026) Table 21. Global Immune System Supplements Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Online Sales Table 23. Significant Companies of Offline Sales Table 24. Global Immune System Supplements Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Immune System Supplements Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Immune System Supplements Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Immune System Supplements Sales Value Share by Application (2021-2026) Table 28. Global Immune System Supplements Sales Value Share by Application (2027-2032) Table 29. Global Immune System Supplements Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Immune System Supplements Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Immune System Supplements Sales Value Share by Region (2021-2026) Table 32. Global Immune System Supplements Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Immune System Supplements Sales Value Share by Region (2027-2032) Table 34. Global Immune System Supplements Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Immune System Supplements Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Immune System Supplements Sales Value Market Share by Country (2021-2026) Table 37. Global Immune System Supplements Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Immune System Supplements Sales Value Market Share by Country (2027-2032) Table 39. USANA Health Sciences Company Information Table 40. USANA Health Sciences Business Overview Table 41. USANA Health Sciences Immune System Supplements Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. USANA Health Sciences Immune System Supplements Product Portfolio Table 43. USANA Health Sciences Recent Development Table 44. Swisse Company Information Table 45. Swisse Business Overview Table 46. Swisse Immune System Supplements Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Swisse Immune System Supplements Product Portfolio Table 48. Swisse Recent Development Table 49. Suntory Company Information Table 50. Suntory Business Overview Table 51. Suntory Immune System Supplements Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Suntory Immune System Supplements Product Portfolio Table 53. Suntory Recent Development Table 54. PERFECT Company Information Table 55. PERFECT Business Overview Table 56. PERFECT Immune System Supplements Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. PERFECT Immune System Supplements Product Portfolio Table 58. PERFECT Recent Development Table 59. INFINITUS Company Information Table 60. INFINITUS Business Overview Table 61. INFINITUS Immune System Supplements Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. INFINITUS Immune System Supplements Product Portfolio Table 63. INFINITUS Recent Development Table 64. Herbalife Nutrition Company Information Table 65. Herbalife Nutrition Business Overview Table 66. Herbalife Nutrition Immune System Supplements Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Herbalife Nutrition Immune System Supplements Product Portfolio Table 68. Herbalife Nutrition Recent Development Table 69. GNC Company Information Table 70. GNC Business Overview Table 71. GNC Immune System Supplements Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. GNC Immune System Supplements Product Portfolio Table 73. GNC Recent Development Table 74. Glanbia Company Information Table 75. Glanbia Business Overview Table 76. Glanbia Immune System Supplements Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Glanbia Immune System Supplements Product Portfolio Table 78. Glanbia Recent Development Table 79. China New Era Group Company Information Table 80. China New Era Group Business Overview Table 81. China New Era Group Immune System Supplements Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. China New Era Group Immune System Supplements Product Portfolio Table 83. China New Era Group Recent Development Table 84. By-health Company Information Table 85. By-health Business Overview Table 86. By-health Immune System Supplements Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. By-health Immune System Supplements Product Portfolio Table 88. By-health Recent Development Table 89. Blackmores Company Information Table 90. Blackmores Business Overview Table 91. Blackmores Immune System Supplements Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Blackmores Immune System Supplements Product Portfolio Table 93. Blackmores Recent Development Table 94. Bayer AG Company Information Table 95. Bayer AG Business Overview Table 96. Bayer AG Immune System Supplements Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Bayer AG Immune System Supplements Product Portfolio Table 98. Bayer AG Recent Development Table 99. Amway Company Information Table 100. Amway Business Overview Table 101. Amway Immune System Supplements Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Amway Immune System Supplements Product Portfolio Table 103. Amway Recent Development Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Immune System Supplements Product Image Figure 2. Global Immune System Supplements Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immune System Supplements Market Size (2021-2032) & (US$ Million) Figure 4. Global Immune System Supplements Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Liquid Image Figure 8. Soft Gels/Pills Image Figure 9. Powder Image Figure 10. Global Immune System Supplements Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Immune System Supplements Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Immune System Supplements Sales Value Share by Type (2021-2032) Figure 13. Online Sales Image Figure 14. Offline Sales Image Figure 15. Global Immune System Supplements Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Immune System Supplements Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Immune System Supplements Sales Value Share by Application (2021-2032) Figure 18. Global Immune System Supplements Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Immune System Supplements Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Immune System Supplements Sales Value (2021-2032) & (US$ Million) Figure 21. North America Immune System Supplements Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Immune System Supplements Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Immune System Supplements Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Immune System Supplements Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Immune System Supplements Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Immune System Supplements Sales Value (2021-2032) & (US$ Million) Figure 27. South America Immune System Supplements Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Immune System Supplements Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Immune System Supplements Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Immune System Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Immune System Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Immune System Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Immune System Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Immune System Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Immune System Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Immune System Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Immune System Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Immune System Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Immune System Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Immune System Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Immune System Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Immune System Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Immune System Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Immune System Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Immune System Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Immune System Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Immune System Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Immune System Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Immune System Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Immune System Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Immune System Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Immune System Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Immune System Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Immune System Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Immune System Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Immune System Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Immune System Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Immune System Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Immune System Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Immune System Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Immune System Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Immune System Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Immune System Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Immune System Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Immune System Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Immune System Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Immune System Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Immune System Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Immune System Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Immune System Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Immune System Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Immune System Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Immune System Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Immune System Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Immune System Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Immune System Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Immune System Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Immune System Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Immune System Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Immune System Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Immune System Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Immune System Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Immune System Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Immune System Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Immune System Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Immune System Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Immune System Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Immune System Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Immune System Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Immune System Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Immune System Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Immune System Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Immune System Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Immune System Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Immune System Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Immune System Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Immune System Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Immune System Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Immune System Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Immune System Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Immune System Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Immune System Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Immune System Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Immune System Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Immune System Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Immune System Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Immune System Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Immune System Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Immune System Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Immune System Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Immune System Supplements Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Immune System Supplements Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Immune System Supplements Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Liquid
  • Soft Gels/Pills
  • Powder
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • USANA Health Sciences
  • Swisse
  • Suntory
  • PERFECT
  • INFINITUS
  • Herbalife Nutrition
  • GNC
  • Glanbia
  • China New Era Group
  • By-health
  • Blackmores
  • Bayer AG
  • Amway

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Immune System Supplements Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Immune System Supplements Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Immune System Supplements Market Dynamics
  1. 2.1 Immune System Supplements Industry Trends
  2. 2.2 Immune System Supplements Industry Drivers
  3. 2.3 Immune System Supplements Industry Opportunities and Challenges
  4. 2.4 Immune System Supplements Industry Restraints
3 Immune System Supplements Market by Company
  1. 3.1 Global Immune System Supplements Company Revenue Ranking in 2025
  2. 3.2 Global Immune System Supplements Revenue by Company (2021-2026)
  3. 3.3 Global Immune System Supplements Company Ranking (2024-2026)
  4. 3.4 Global Immune System Supplements Company Manufacturing Base and Headquarters
  5. 3.5 Global Immune System Supplements Company Product Type and Application
  6. 3.6 Global Immune System Supplements Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Immune System Supplements Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Immune System Supplements Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Immune System Supplements Market by Type
  1. 4.1 Immune System Supplements Type Introduction
  2. 4.1.1 Liquid
  3. 4.1.2 Soft Gels/Pills
  4. 4.1.3 Powder
  5. 4.2 Global Immune System Supplements Sales Value by Type
  6. 4.2.1 Global Immune System Supplements Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Immune System Supplements Sales Value by Type (2021-2032)
  8. 4.2.3 Global Immune System Supplements Sales Value Share by Type (2021-2032)
5 Immune System Supplements Market by Application
  1. 5.1 Immune System Supplements Application Introduction
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global Immune System Supplements Sales Value by Application
  5. 5.2.1 Global Immune System Supplements Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Immune System Supplements Sales Value by Application (2021-2032)
  7. 5.2.3 Global Immune System Supplements Sales Value Share by Application (2021-2032)
6 Immune System Supplements Regional Value Analysis
  1. 6.1 Global Immune System Supplements Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Immune System Supplements Sales Value by Region (2021-2032)
  3. 6.2.1 Global Immune System Supplements Sales Value by Region: 2021-2026
  4. 6.2.2 Global Immune System Supplements Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Immune System Supplements Sales Value (2021-2032)
  7. 6.3.2 North America Immune System Supplements Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Immune System Supplements Sales Value (2021-2032)
  10. 6.4.2 Europe Immune System Supplements Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Immune System Supplements Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Immune System Supplements Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Immune System Supplements Sales Value (2021-2032)
  16. 6.6.2 South America Immune System Supplements Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Immune System Supplements Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Immune System Supplements Sales Value Share by Country, 2025 VS 2032
7 Immune System Supplements Country-level Value Analysis
  1. 7.1 Global Immune System Supplements Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Immune System Supplements Sales Value by Country (2021-2032)
  3. 7.2.1 Global Immune System Supplements Sales Value by Country (2021-2026)
  4. 7.2.2 Global Immune System Supplements Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Immune System Supplements Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Immune System Supplements Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Immune System Supplements Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Immune System Supplements Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Immune System Supplements Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Immune System Supplements Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Immune System Supplements Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Immune System Supplements Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Immune System Supplements Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Immune System Supplements Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Immune System Supplements Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Immune System Supplements Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Immune System Supplements Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Immune System Supplements Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Immune System Supplements Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Immune System Supplements Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Immune System Supplements Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Immune System Supplements Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Immune System Supplements Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Immune System Supplements Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Immune System Supplements Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Immune System Supplements Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Immune System Supplements Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Immune System Supplements Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Immune System Supplements Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Immune System Supplements Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Immune System Supplements Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Immune System Supplements Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Immune System Supplements Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Immune System Supplements Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Immune System Supplements Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Immune System Supplements Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Immune System Supplements Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Immune System Supplements Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Immune System Supplements Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Immune System Supplements Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Immune System Supplements Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Immune System Supplements Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Immune System Supplements Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Immune System Supplements Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Immune System Supplements Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Immune System Supplements Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Immune System Supplements Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Immune System Supplements Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Immune System Supplements Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Immune System Supplements Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Immune System Supplements Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Immune System Supplements Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Immune System Supplements Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Immune System Supplements Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Immune System Supplements Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Immune System Supplements Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Immune System Supplements Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Immune System Supplements Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Immune System Supplements Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Immune System Supplements Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Immune System Supplements Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Immune System Supplements Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Immune System Supplements Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Immune System Supplements Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Immune System Supplements Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Immune System Supplements Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Immune System Supplements Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Immune System Supplements Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Immune System Supplements Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Immune System Supplements Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Immune System Supplements Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Immune System Supplements Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Immune System Supplements Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Immune System Supplements Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Immune System Supplements Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Immune System Supplements Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Immune System Supplements Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Immune System Supplements Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Immune System Supplements Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Immune System Supplements Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Immune System Supplements Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Immune System Supplements Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Immune System Supplements Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Immune System Supplements Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Immune System Supplements Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Immune System Supplements Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Immune System Supplements Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Immune System Supplements Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 USANA Health Sciences
  2. 8.1.1 USANA Health Sciences Company Information
  3. 8.1.2 USANA Health Sciences Business Overview
  4. 8.1.3 USANA Health Sciences Immune System Supplements Revenue and Gross Margin (2021-2026)
  5. 8.1.4 USANA Health Sciences Immune System Supplements Product Portfolio
  6. 8.1.5 USANA Health Sciences Recent Developments
  7. 8.2 Swisse
  8. 8.2.1 Swisse Company Information
  9. 8.2.2 Swisse Business Overview
  10. 8.2.3 Swisse Immune System Supplements Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Swisse Immune System Supplements Product Portfolio
  12. 8.2.5 Swisse Recent Developments
  13. 8.3 Suntory
  14. 8.3.1 Suntory Company Information
  15. 8.3.2 Suntory Business Overview
  16. 8.3.3 Suntory Immune System Supplements Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Suntory Immune System Supplements Product Portfolio
  18. 8.3.5 Suntory Recent Developments
  19. 8.4 PERFECT
  20. 8.4.1 PERFECT Company Information
  21. 8.4.2 PERFECT Business Overview
  22. 8.4.3 PERFECT Immune System Supplements Revenue and Gross Margin (2021-2026)
  23. 8.4.4 PERFECT Immune System Supplements Product Portfolio
  24. 8.4.5 PERFECT Recent Developments
  25. 8.5 INFINITUS
  26. 8.5.1 INFINITUS Company Information
  27. 8.5.2 INFINITUS Business Overview
  28. 8.5.3 INFINITUS Immune System Supplements Revenue and Gross Margin (2021-2026)
  29. 8.5.4 INFINITUS Immune System Supplements Product Portfolio
  30. 8.5.5 INFINITUS Recent Developments
  31. 8.6 Herbalife Nutrition
  32. 8.6.1 Herbalife Nutrition Company Information
  33. 8.6.2 Herbalife Nutrition Business Overview
  34. 8.6.3 Herbalife Nutrition Immune System Supplements Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Herbalife Nutrition Immune System Supplements Product Portfolio
  36. 8.6.5 Herbalife Nutrition Recent Developments
  37. 8.7 GNC
  38. 8.7.1 GNC Company Information
  39. 8.7.2 GNC Business Overview
  40. 8.7.3 GNC Immune System Supplements Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GNC Immune System Supplements Product Portfolio
  42. 8.7.5 GNC Recent Developments
  43. 8.8 Glanbia
  44. 8.8.1 Glanbia Company Information
  45. 8.8.2 Glanbia Business Overview
  46. 8.8.3 Glanbia Immune System Supplements Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Glanbia Immune System Supplements Product Portfolio
  48. 8.8.5 Glanbia Recent Developments
  49. 8.9 China New Era Group
  50. 8.9.1 China New Era Group Company Information
  51. 8.9.2 China New Era Group Business Overview
  52. 8.9.3 China New Era Group Immune System Supplements Revenue and Gross Margin (2021-2026)
  53. 8.9.4 China New Era Group Immune System Supplements Product Portfolio
  54. 8.9.5 China New Era Group Recent Developments
  55. 8.10 By-health
  56. 8.10.1 By-health Company Information
  57. 8.10.2 By-health Business Overview
  58. 8.10.3 By-health Immune System Supplements Revenue and Gross Margin (2021-2026)
  59. 8.10.4 By-health Immune System Supplements Product Portfolio
  60. 8.10.5 By-health Recent Developments
  61. 8.11 Blackmores
  62. 8.11.1 Blackmores Company Information
  63. 8.11.2 Blackmores Business Overview
  64. 8.11.3 Blackmores Immune System Supplements Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Blackmores Immune System Supplements Product Portfolio
  66. 8.11.5 Blackmores Recent Developments
  67. 8.12 Bayer AG
  68. 8.12.1 Bayer AG Company Information
  69. 8.12.2 Bayer AG Business Overview
  70. 8.12.3 Bayer AG Immune System Supplements Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Bayer AG Immune System Supplements Product Portfolio
  72. 8.12.5 Bayer AG Recent Developments
  73. 8.13 Amway
  74. 8.13.1 Amway Company Information
  75. 8.13.2 Amway Business Overview
  76. 8.13.3 Amway Immune System Supplements Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Amway Immune System Supplements Product Portfolio
  78. 8.13.5 Amway Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research